Litigation Details for ABRAXIS BIOSCIENCE, LLC v. ACTAVIS LLC (D.N.J. 2016)
✉ Email this page to a colleague
ABRAXIS BIOSCIENCE, LLC v. ACTAVIS LLC (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-04-06 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-01-26 |
| Cause | 35:271 Patent Infringement | Assigned To | John Michael Vazquez |
| Jury Demand | None | Referred To | Mark Falk |
| Parties | ABRAXIS BIOSCIENCE, LLC | ||
| Patents | 6,210,705; 6,348,211; 7,820,788; 7,923,536; 8,138,229; 8,217,083; 8,436,051; 8,853,260 | ||
| Attorneys | HECTOR DANIEL RUIZ | ||
| Firms | Quinn Emanuel Urquhart & Sullivan, LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ABRAXIS BIOSCIENCE, LLC v. ACTAVIS LLC
Details for ABRAXIS BIOSCIENCE, LLC v. ACTAVIS LLC (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-04-13 | 69 | products infringe U.S. Patent Nos. 6,210,705 (“’705 patent”) and 6,348,211 (“’211 patent”) (collectively… patenting over the ’444 patent, Janssen failed to assert that the ’471 patent was patentably … of the ’471 patent are not patentably dis- tinct over at least three of those patents. There are well-settled…variants—once the patent expires. Thus, where an inventor holds multiple patents that are not patentably distinct…double patenting precedent, Janssen knew that other patents it had that were not “patentably distinct | External link to document | |
| 2017-05-15 | 83 | infringe four patents: U.S. Patent Nos. 8,853,260 (“‘260 patent”); 7,820,788 (“‘788 patent”); 7,923,536…7,923,536 (“‘536 patent”); and 8,138,229 (“‘229 patent”). The Complaint was filed on April 6, 2016. …obviousness-type double patenting (“OTDP”) against the asserted claims of the ‘788 patent based on the Janssen…Defendant. FALK, U.S.M.J. This is an ANDA patent case. Before the Court is Defendant Actavis’s motion… RELEVANT BACKGROUND This Hatch-Waxman patent infringement case arises out of Actavis’s filing | External link to document | |
| 2017-05-25 | 92 | infringe four patents: U.S. Patent Nos. 8,853,260 (“‘260 patent”); 7,820,788 (“‘788 patent”); 7,923,536…7,923,536 (“‘536 patent”); and 8,138,229 (“‘229 patent”). The initial scheduling conference was held on August… RELEVANT BACKGROUND This Hatch-Waxman patent infringement case arises out of Actavis’s filing…involved and proportionate to the needs of this large patent case. Fifth, to the extent there is any…resources.” Fed. R. Civ. P. 26(b)(1). This is a patent case involving substantial sums, in monetary terms | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
